Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ettenberg

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Oncogene|March 23, 1999
cbl-b inhibits epidermal growth factor receptor signalingS A Ettenberg, M M Keane, M M Nau, et al.
The Journal of Biological Chemistry|May 26, 2001
Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complexS A Ettenberg, A Magnifico, M Cuello, et al.
Oncogene|July 27, 2004
Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-bGareth C Davies, Seth A Ettenberg, Ashley O Coats, et al.
Neuropharmacology|March 1, 1983
Chemical and physiological aspects of the actions of lithium and antidepressant drugsF E Bloom, G Baetge, S Deyo, et al.
Cancer Research|June 19, 2001
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2M Cuello, S A Ettenberg, A S Clark, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 2013
Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activityMing-Kang Chang, Ina Kramer, Hansjoerg Keller, et al.
Cell Death and Differentiation|February 7, 2004
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell linesM Cuello, A O Coats, I Darko, et al.
Psychoneuroendocrinology|January 1, 1984
Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesisM Le Moal, R Dantzer, P Mormède, et al.
Molecular Cell|January 15, 2000
Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1G Levkowitz, H Waterman, S A Ettenberg, et al.
Cancer Research|August 7, 2013
Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancersJoan T Garrett, Cammie R Sutton, Richard Kurupi, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Oncogene|March 23, 1999
cbl-b inhibits epidermal growth factor receptor signalingS A Ettenberg, M M Keane, M M Nau, et al.
The Journal of Biological Chemistry|May 26, 2001
Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complexS A Ettenberg, A Magnifico, M Cuello, et al.
Oncogene|July 27, 2004
Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-bGareth C Davies, Seth A Ettenberg, Ashley O Coats, et al.
Neuropharmacology|March 1, 1983
Chemical and physiological aspects of the actions of lithium and antidepressant drugsF E Bloom, G Baetge, S Deyo, et al.
Cancer Research|June 19, 2001
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2M Cuello, S A Ettenberg, A S Clark, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 2013
Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activityMing-Kang Chang, Ina Kramer, Hansjoerg Keller, et al.
Cell Death and Differentiation|February 7, 2004
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell linesM Cuello, A O Coats, I Darko, et al.
Psychoneuroendocrinology|January 1, 1984
Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesisM Le Moal, R Dantzer, P Mormède, et al.
Molecular Cell|January 15, 2000
Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1G Levkowitz, H Waterman, S A Ettenberg, et al.
Cancer Research|August 7, 2013
Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancersJoan T Garrett, Cammie R Sutton, Richard Kurupi, et al.
Pageof 10